Copyright Reports & Markets. All rights reserved.

Global IV and Oral Iron Drugs Market Size, Status and Forecast 2019-2025

Request for Sample of this report
Buy now

Table of Contents

    1 Report Overview

    • 1.1 Study Scope
    • 1.2 Key Market Segments
    • 1.3 Players Covered
    • 1.4 Market Analysis by Type
      • 1.4.1 Global IV and Oral Iron Drugs Market Size Growth Rate by Type (2014-2025)
      • 1.4.2 Oral Iron Drug
      • 1.4.3 IVIron Drugs
    • 1.5 Market by Application
      • 1.5.1 Global IV and Oral Iron Drugs Market Share by Application (2019-2025)
      • 1.5.2 Nephrology
      • 1.5.3 OBGYN
      • 1.5.4 Surgeries
      • 1.5.5 Gastroenterology
      • 1.5.6 Oncology
      • 1.5.7 Heart failure (HF)
    • 1.6 Study Objectives
    • 1.7 Years Considered

    2 Global Growth Trends

    • 2.1 IV and Oral Iron Drugs Market Size
    • 2.2 IV and Oral Iron Drugs Growth Trends by Regions
      • 2.2.1 IV and Oral Iron Drugs Market Size by Regions (2019-2025)
      • 2.2.2 IV and Oral Iron Drugs Market Share by Regions (2014-2019)
    • 2.3 Industry Trends
      • 2.3.1 Market Top Trends
      • 2.3.2 Market Drivers
      • 2.3.3 Market Challenges
      • 2.3.4 Porter’s Five Forces Analysis

    3 Market Share by Key Players

    • 3.1 IV and Oral Iron Drugs Market Size by by Players
      • 3.1.1 Global IV and Oral Iron Drugs Revenue by by Players (2014-2019)
      • 3.1.2 Global IV and Oral Iron Drugs Revenue Market Share by by Players (2014-2019)
      • 3.1.3 Global IV and Oral Iron Drugs Market Concentration Ratio (CR5 and HHI)
    • 3.2 IV and Oral Iron Drugs Key Players Head office and Area Served
    • 3.3 Key Players IV and Oral Iron Drugs Product/Solution/Service
    • 3.4 Date of Enter into IV and Oral Iron Drugs Market
    • 3.5 Mergers & Acquisitions, Expansion Plans

    4 Breakdown Data by Type and Application

    • 4.1 Global IV and Oral Iron Drugs Market Size by Type (2014-2019)
    • 4.2 Global IV and Oral Iron Drugs Market Size by Application (2014-2019)

    5 North America

    • 5.1 North America IV and Oral Iron Drugs Market Size (2014-2019)
    • 5.2 IV and Oral Iron Drugs Key Players in North America
    • 5.3 North America IV and Oral Iron Drugs Market Size by Type
    • 5.4 North America IV and Oral Iron Drugs Market Size by Application

    6 Europe

    • 6.1 Europe IV and Oral Iron Drugs Market Size (2014-2019)
    • 6.2 IV and Oral Iron Drugs Key Players in Europe
    • 6.3 Europe IV and Oral Iron Drugs Market Size by Type
    • 6.4 Europe IV and Oral Iron Drugs Market Size by Application

    7 China

    • 7.1 China IV and Oral Iron Drugs Market Size (2014-2019)
    • 7.2 IV and Oral Iron Drugs Key Players in China
    • 7.3 China IV and Oral Iron Drugs Market Size by Type
    • 7.4 China IV and Oral Iron Drugs Market Size by Application

    8 Japan

    • 8.1 Japan IV and Oral Iron Drugs Market Size (2014-2019)
    • 8.2 IV and Oral Iron Drugs Key Players in Japan
    • 8.3 Japan IV and Oral Iron Drugs Market Size by Type
    • 8.4 Japan IV and Oral Iron Drugs Market Size by Application

    9 Southeast Asia

    • 9.1 Southeast Asia IV and Oral Iron Drugs Market Size (2014-2019)
    • 9.2 IV and Oral Iron Drugs Key Players in Southeast Asia
    • 9.3 Southeast Asia IV and Oral Iron Drugs Market Size by Type
    • 9.4 Southeast Asia IV and Oral Iron Drugs Market Size by Application

    10 India

    • 10.1 India IV and Oral Iron Drugs Market Size (2014-2019)
    • 10.2 IV and Oral Iron Drugs Key Players in India
    • 10.3 India IV and Oral Iron Drugs Market Size by Type
    • 10.4 India IV and Oral Iron Drugs Market Size by Application

    11 Central & South America

    • 11.1 Central & South America IV and Oral Iron Drugs Market Size (2014-2019)
    • 11.2 IV and Oral Iron Drugs Key Players in Central & South America
    • 11.3 Central & South America IV and Oral Iron Drugs Market Size by Type
    • 11.4 Central & South America IV and Oral Iron Drugs Market Size by Application

    12 International Players Profiles

    • 12.1 Daiichi Sankyo Company
      • 12.1.1 Daiichi Sankyo Company Company Details
      • 12.1.2 Company Description and Business Overview
      • 12.1.3 IV and Oral Iron Drugs Introduction
      • 12.1.4 Daiichi Sankyo Company Revenue in IV and Oral Iron Drugs Business (2014-2019))
      • 12.1.5 Daiichi Sankyo Company Recent Development
    • 12.2 Vifor Pharma
      • 12.2.1 Vifor Pharma Company Details
      • 12.2.2 Company Description and Business Overview
      • 12.2.3 IV and Oral Iron Drugs Introduction
      • 12.2.4 Vifor Pharma Revenue in IV and Oral Iron Drugs Business (2014-2019)
      • 12.2.5 Vifor Pharma Recent Development
    • 12.3 Akebia Therapeutics
      • 12.3.1 Akebia Therapeutics Company Details
      • 12.3.2 Company Description and Business Overview
      • 12.3.3 IV and Oral Iron Drugs Introduction
      • 12.3.4 Akebia Therapeutics Revenue in IV and Oral Iron Drugs Business (2014-2019)
      • 12.3.5 Akebia Therapeutics Recent Development
    • 12.4 Allergan
      • 12.4.1 Allergan Company Details
      • 12.4.2 Company Description and Business Overview
      • 12.4.3 IV and Oral Iron Drugs Introduction
      • 12.4.4 Allergan Revenue in IV and Oral Iron Drugs Business (2014-2019)
      • 12.4.5 Allergan Recent Development
    • 12.5 AMAG Pharmaceuticals
      • 12.5.1 AMAG Pharmaceuticals Company Details
      • 12.5.2 Company Description and Business Overview
      • 12.5.3 IV and Oral Iron Drugs Introduction
      • 12.5.4 AMAG Pharmaceuticals Revenue in IV and Oral Iron Drugs Business (2014-2019)
      • 12.5.5 AMAG Pharmaceuticals Recent Development
    • 12.6 AOP Orphan Pharmaceuticals
      • 12.6.1 AOP Orphan Pharmaceuticals Company Details
      • 12.6.2 Company Description and Business Overview
      • 12.6.3 IV and Oral Iron Drugs Introduction
      • 12.6.4 AOP Orphan Pharmaceuticals Revenue in IV and Oral Iron Drugs Business (2014-2019)
      • 12.6.5 AOP Orphan Pharmaceuticals Recent Development
    • 12.7 Pharmacosmos
      • 12.7.1 Pharmacosmos Company Details
      • 12.7.2 Company Description and Business Overview
      • 12.7.3 IV and Oral Iron Drugs Introduction
      • 12.7.4 Pharmacosmos Revenue in IV and Oral Iron Drugs Business (2014-2019)
      • 12.7.5 Pharmacosmos Recent Development
    • 12.8 Sanofi
      • 12.8.1 Sanofi Company Details
      • 12.8.2 Company Description and Business Overview
      • 12.8.3 IV and Oral Iron Drugs Introduction
      • 12.8.4 Sanofi Revenue in IV and Oral Iron Drugs Business (2014-2019)
      • 12.8.5 Sanofi Recent Development
    • 12.9 Shield Therapeutics
      • 12.9.1 Shield Therapeutics Company Details
      • 12.9.2 Company Description and Business Overview
      • 12.9.3 IV and Oral Iron Drugs Introduction
      • 12.9.4 Shield Therapeutics Revenue in IV and Oral Iron Drugs Business (2014-2019)
      • 12.9.5 Shield Therapeutics Recent Development
    • 12.10 AZAD Pharma
      • 12.10.1 AZAD Pharma Company Details
      • 12.10.2 Company Description and Business Overview
      • 12.10.3 IV and Oral Iron Drugs Introduction
      • 12.10.4 AZAD Pharma Revenue in IV and Oral Iron Drugs Business (2014-2019)
      • 12.10.5 AZAD Pharma Recent Development
    • 12.11 Cirondrugs
    • 12.12 MEDICE
    • 12.13 Pfizer
    • 12.14 Salveo Lifecare
    • 12.15 Sunny Pharmaceutical

    13 Market Forecast 2019-2025

    • 13.1 Market Size Forecast by Product (2019-2025)
    • 13.2 Market Size Forecast by Application (2019-2025)
    • 13.3 Market Size Forecast by Regions
    • 13.4 North America
    • 13.5 Europe
    • 13.6 China
    • 13.7 Japan
    • 13.8 Southeast Asia
    • 13.9 India
    • 13.10 Central & South America

    14 Analyst's Viewpoints/Conclusions

      15 Appendix

      • 15.1 Research Methodology
        • 15.1.1 Methodology/Research Approach
          • 15.1.1.1 Research Programs/Design
          • 15.1.1.2 Market Size Estimation
          • 15.1.1.3 Market Breakdown and Data Triangulation
        • 15.1.2 Data Source
          • 15.1.2.1 Secondary Sources
          • 15.1.2.2 Primary Sources
      • 15.2 Disclaimer

      This report focuses on the global IV and Oral Iron Drugs status, future forecast, growth opportunity, key market and key players. The study objectives are to present the IV and Oral Iron Drugs development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.

      The key players covered in this study
      Daiichi Sankyo Company
      Vifor Pharma
      Akebia Therapeutics
      Allergan
      AMAG Pharmaceuticals
      AOP Orphan Pharmaceuticals
      Pharmacosmos
      Sanofi
      Shield Therapeutics
      AZAD Pharma
      Cirondrugs
      MEDICE
      Pfizer
      Salveo Lifecare
      Sunny Pharmaceutical

      Market segment by Type, the product can be split into
      Oral Iron Drug
      IVIron Drugs

      Market segment by Application, split into
      Nephrology
      OBGYN
      Surgeries
      Gastroenterology
      Oncology
      Heart failure (HF)

      Market segment by Regions/Countries, this report covers
      North America
      Europe
      China
      Japan
      Southeast Asia
      India
      Central & South America

      The study objectives of this report are:
      To analyze global IV and Oral Iron Drugs status, future forecast, growth opportunity, key market and key players.
      To present the IV and Oral Iron Drugs development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
      To strategically profile the key players and comprehensively analyze their development plan and strategies.
      To define, describe and forecast the market by product type, market and key regions.

      In this study, the years considered to estimate the market size of IV and Oral Iron Drugs are as follows:
      History Year: 2014-2018
      Base Year: 2018
      Estimated Year: 2019
      Forecast Year 2019 to 2025
      For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
      Buy now